Pediatric Dermatology Research Alliance

Contact
Events
For Researchers
- - - Apply for a Grant
      
      Applications are now being accepted for 2020 PeDRA Research Grants. As many as six one-year, $15,000 awards will be given to individuals or teams conducting early stage pediatric dermatology research.
For Patients & Families
- - - COVID-19 Information
    - PeDRA Publications
  - - Explore webinars to connect patients and families to the research process and foster engagement between patients and scientists in the field.
Our Research
- - - PeDRA Studies
      
      Applications being accepted for new and ongoing studies and surveys to receive special benefits as “PeDRA Studies.”
About
- - - PeDRA is an independent 501(c)(3) nonprofit organization driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.
Member Login

Psoriasis and psoriasiform reactions in children receiving anti-TNF medications

November 10, 2019 By Mike Siegel

Principal Investigators:

Megha Tollefson, MD
Mayo Clinic

Amy Paller, MD
Northwestern University

Overview:

Children on anti-TNF agents have been reported to develop psoriasis, but the majority of the literature is in the gastrointestinal (GI) literature and focuses on infliximab and inflammatory bowel disease. Not much is known about other primary disease processes and other medications, nor risk factors to develop this paradoxical reaction. This study is a retrospective multi-center review to further characterize this process.

Status:

Enrollment is complete, and a manuscript is being prepared for publication.

Principal Investigators:

Overview:

Status:

Participating Sites:

Footer